In search of the original leukemic clone in chronic myeloid leukemia patients in complete molecular remission after stem cell transplantation or imatinib.
about
Kinase-independent mechanisms of resistance of leukemia stem cells to tyrosine kinase inhibitorsCurrent developments in molecular monitoring in chronic myeloid leukemiaAHI-1: a novel signaling protein and potential therapeutic target in human leukemia and brain disorders.JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivo.Genomic quantitative real-time PCR proves residual disease positivity in more than 30% samples with negative mRNA-based qRT-PCR in Chronic Myeloid LeukemiaIL1RAP as a surface marker for leukemia stem cells is related to clinical phase of chronic myeloid leukemia patients.Clinical and biological predictors of outcome following relapse of CML post-allo-SCTDurable complete molecular remission of chronic myeloid leukemia following dasatinib cessation, despite adverse disease features.Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatmentLaboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia.Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy.Flow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR TechniquesChronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survivalEuropean LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells.Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual diseaseNecrotizing Liver Granuloma/Abscess and Constrictive Aspergillosis Pericarditis with Central Nervous System Involvement: Different Remarkable Phenotypes in Different Chronic Granulomatous Disease Genotypes.Molecular techniques for the personalised management of patients with chronic myeloid leukaemia.Do we have to kill the last CML cell?Chronic myeloid leukemia stem cells and developing therapies.Chronic myelogenous leukemia: monitoring response to therapy.Standardized definitions of molecular response in chronic myeloid leukemia.Molecular monitoring.Definition and treatment of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia.Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardization.Transplant to treatment-free remission: the evolving view of 'cure' in chronic myeloid leukemia.Present and future of molecular monitoring in chronic myeloid leukaemia.Characterization of 46 patient-specific BCR-ABL1 fusions and detection of SNPs upstream and downstream the breakpoints in chronic myeloid leukemia using next generation sequencing.Minimal residual disease: the advantages of digital over analog polymerase chain reaction.Where are we going with CML research?Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuationDistribution of genomic breakpoints in chronic myeloid leukemia: analysis of 308 patients.Molecular monitoring 101: helping your patients with chronic myeloid leukemia to understand the meaning of molecular response.Leukemia stem cells.gDNA qPCR is statistically more reliable than mRNA analysis in detecting leukemic cells to monitor CML.Genomic BCR-ABL1 breakpoints in pediatric chronic myeloid leukemia.Evaluation of the primitive fraction by functional in vitro assays at the RNA and DNA level represents a novel tool for complementing molecular monitoring in chronic myeloid leukemia.On the persistence of the primitive chronic myeloid leukaemia cell in patients in complete molecular response.
P2860
Q26849792-005B4B03-07E3-45F6-9B14-4C4397AD3E5AQ28066148-FDC3354F-8558-4690-AC8D-FABAFA5AB2FFQ30010179-5F21B958-CF52-4389-BD0E-DCAF0EF5666AQ34106870-21D0E846-9474-48C3-93EB-ED2F4982F967Q34781322-B3AC3F7E-E7FF-4CEC-83FC-9DA80A880AD3Q35016953-C1E4CFF7-C054-48AF-8D33-51EDD13D94EAQ35054717-52428121-64AB-4F72-8D1A-5E2C78A687B2Q35528735-7C996A3E-D627-4CB6-B768-E569F271D29DQ35553345-CAD1AB73-DA37-441F-BA73-A6E3BF763671Q35603605-E4AEC941-D03C-4FBA-B6D6-864468D96403Q35640320-13864446-7662-46B4-984A-6BF19DEAA9E4Q35674595-BC07F733-E312-4A34-A2E8-C258B4D54966Q35776432-19284C0A-8992-4C60-9D27-7AD63A227E43Q37026032-01153C51-7DCA-474A-B8FA-FB83C81F5AACQ37200863-49CAA232-2B49-4A04-B465-AF58BCE62362Q37511071-05CD578B-C25A-40D6-B5CE-D7E612D20FEAQ37601820-3BA62476-4D2F-4C34-9662-E42C6D06FCD9Q37696776-7F84A08D-5708-4ABA-B659-E7C117FFDEE2Q37789148-30AFEBA1-B221-4A76-A8AB-FDBBEE20EA7FQ37836936-989E39FB-0E25-4549-B779-B912CE8281E2Q37848207-BF19819D-83A3-4F19-BD12-0C3FD764EE50Q38002704-ED399B8C-F98D-4D15-88C7-1A15CA09A29EQ38176284-88B1ABB6-D683-4518-B0AC-B69C290C35B7Q38199143-9AB34D2A-2EB3-4F20-B91C-03C2156E6C6AQ38392702-6CBC95F7-A84A-472C-A43B-4BE12482C0FEQ38585916-3650BE38-8A08-4C76-8CB6-F2E063C47DC2Q38762631-52A0BA31-2C44-4BF3-8065-05E4855E9C2AQ39961918-F795A9D4-26CA-4E74-905D-80C42821BFBBQ39984424-7718182E-2F01-4FAA-9E9D-C687AA3F7696Q40817656-03F71D77-8330-4B02-A9B5-8204350F2E04Q41610510-FC101478-9E57-4F02-BF5B-9ED733015449Q44765741-EC23F4AC-D0C5-4784-BDBE-CDED54BD3EF5Q53136807-8867D33E-DCFF-4F60-B8AD-A3F17A02E37FQ53293069-7A5E7B03-B8D0-47D2-B25C-8ABB5D557DF5Q54123354-5203837E-3602-4259-AACB-F6DB09CA8CD0Q54491280-63519F90-4984-417A-882F-A1A87B894FE3Q54979166-1229EEF8-BFAD-4A3D-8FB6-E9E2258EBBAEQ55083219-61A0EA97-7785-4879-9825-53E9D500CAA8
P2860
In search of the original leukemic clone in chronic myeloid leukemia patients in complete molecular remission after stem cell transplantation or imatinib.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
In search of the original leuk ...... l transplantation or imatinib.
@en
In search of the original leuk ...... l transplantation or imatinib.
@nl
type
label
In search of the original leuk ...... l transplantation or imatinib.
@en
In search of the original leuk ...... l transplantation or imatinib.
@nl
prefLabel
In search of the original leuk ...... l transplantation or imatinib.
@en
In search of the original leuk ...... l transplantation or imatinib.
@nl
P2093
P1433
P1476
In search of the original leuk ...... ll transplantation or imatinib
@en
P2093
Jane F Apperley
Joannah Score
Junia V Melo
Vicki Wilczek
P304
P356
10.1182/BLOOD-2009-11-255109
P407
P577
2010-05-12T00:00:00Z